| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000003192 |
| Receipt No. | R000003840 |
| Official scientific title of the study | Additive effects of short-acting bronchodilators in COPD patients who still had dyspnea in their daily lives despite long-acting bronchodilators. |
| Date of disclosure of the study information | 2010/03/01 |
| Last modified on | 2017/08/31 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Additive effects of short-acting bronchodilators in COPD patients who still had dyspnea in their daily lives despite long-acting bronchodilators. | |
| Title of the study (Brief title) | Additive effects of short-acting bronchodilators on dyspnea in COPD. | |
| Region |
|
|
| Condition | ||
| Condition | Chronic obstructive pulmonary disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose in this study is to examine additive effects of short-acting bronchodilators, beta-2-agonist or anti-cholinergic agent, on dyspnea on exertion and exercise tolerance in moderate to severe COPD patients who still had dyspnea in their daily lives despite therapy of long-acting bronchodilators including tiotropium at least. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Exercise tolerance and maximum Borg Scale for dyspnea on shuttle walking test. |
| Key secondary outcomes | Spirometry and dynamic hyperinflation. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Single inhalation of procaterol hydrochloride 20 microgram. | |
| Interventions/Control_2 | Single inhalation of oxytropium bromide 0.2 mg. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients with moderate to severe chronic obstructive pulmonary disease (COPD) in stable phase, who recruited from outpatient clinic of Shinshu University Hospital and still have dyspnea on exertion despite therapy with long-acting bronchodilators including tiotropium at least. | |||
| Key exclusion criteria | The patients who considered to have risks for exercise test, such as coronary vascular disease, arythmia, and heart failure are excluded from this study. | |||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Keisaku Fujimoto |
| Organization | Shinshu University School of Medicine |
| Division name | Department of Biomedical Laboratory Sciences, Health Sciences |
| Address | 3-1-1, Asahi, Matsumoto, Nagano, Japan |
| TEL | 0263-37-2393 |
| keisaku@shinshu-u.ac.jp | |
| Public contact | |
| Name of contact person | Keisaku Fujimoto |
| Organization | Shinshu University School of Mdedicine |
| Division name | Department of Biomedical Laboratory Sciences, Health Sciences |
| Address | 3-1-1, Asahi, Matsumoto, Nagano, Japan |
| TEL | 0263-37-2393 |
| Homepage URL | |
| keisaku@shinshu-u.ac.jp | |
| Sponsor | |
| Institute | Department of Biomedical Laboratory Sciences, Shinshu University School of Health Sciences. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Subscription money |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 信州大学医学部付属病院(長野県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003840 |